Search Clinical Trials
597,783 trials
ID
Status
Phase
Title
Sponsor
NCT07758569
Validation of the Artificial Intelligence Subsystem of the DDART Medical Device for the Automated Detection of Lesions Compatible With Glaucoma in a Random Sample of Retinal Fundus PhotographsDemocritus University of ThraceRecruiting
NCT07758569Recruiting
—
Validation of the Artificial Intelligence Subsystem of the DDART Medical Device...Democritus University of...
NCT07758283
Intergenerational Risk and Resilience of Rohingya in DisplacementInternational Centre for Diarrhoeal Disease Research, BangladeshActive Not Recruiting
NCT07758283Active Not Recruiting
—
Intergenerational Risk and Resilience of Rohingya in DisplacementInternational Centre for...
NCT07756827
Surgical Stabilization of Anterior Shoulder Instability Using the Open Latarjet Procedure, With or Without Anterior Capsuloplasty Using the Coracoacromial Ligament.Clinique Générale dAnnecyNot Yet RecruitingNot Applicable
NCT07756827Not Yet Recruiting
Not Applicable
Surgical Stabilization of Anterior Shoulder Instability Using the Open Latarjet...Clinique Générale dAnnecy
NCT07757009
Perioperative Forced-Air Warming During Elective Cesarean Delivery Under Spinal AnesthesiaHamad Medical CorporationCompletedNot Applicable
NCT07757009Completed
Not Applicable
Perioperative Forced-Air Warming During Elective Cesarean Delivery Under Spinal...Hamad Medical Corporation
NCT07756918
Effects of Extracorporeal Shockwave Therapy Versus Dry Needling on Jumpers KneeRiphah International UniversityRecruitingNot Applicable
NCT07756918Recruiting
Not Applicable
Effects of Extracorporeal Shockwave Therapy Versus Dry Needling on Jumpers KneeRiphah International Univ...
NCT07758257
Biodiversity and Human Functioning Following Acquired Cerebrovascular Lesions - Phase 2 (EspertaMente)Dr. Franco MolteniCompletedNot Applicable
NCT07758257Completed
Not Applicable
Biodiversity and Human Functioning Following Acquired Cerebrovascular Lesions -...Dr. Franco Molteni
NCT07758868
Residual Neuromuscular Blockade and PACU AdmissionAnkara Etlik City HospitalNot Yet Recruiting
NCT07758868Not Yet Recruiting
—
Residual Neuromuscular Blockade and PACU AdmissionAnkara Etlik City Hospita...
NCT07756723
The Many Roads to Trauma Recovery: A Clinical Trial Comparing Empirically Supported Treatments for Veterans With Co-Morbid Posttraumatic Stress and Substance Use Disorder SymptomsCoatesville VA Medical CenterRecruitingPhase 2
NCT07756723Recruiting
Phase 2
The Many Roads to Trauma Recovery: A Clinical Trial Comparing Empirically Suppor...Coatesville VA Medical Ce...
NCT07757984
Regional Nerve Block for Upper Extremity Surgery in Patients With SarcopeniaChang Gung Memorial HospitalNot Yet Recruiting
NCT07757984Not Yet Recruiting
—
Regional Nerve Block for Upper Extremity Surgery in Patients With SarcopeniaChang Gung Memorial Hospi...
NCT07757191
DURATION-GC: FLOT Plus Durvalumab and TS-1 Plus Durvalumab for Resectable Gastric CancerTaipei Veterans General Hospital, TaiwanNot Yet RecruitingPhase 2
NCT07757191Not Yet Recruiting
Phase 2
DURATION-GC: FLOT Plus Durvalumab and TS-1 Plus Durvalumab for Resectable Gastri...Taipei Veterans General H...
NCT07757607
A Prospective, Multicenter, Single-Arm Study to Support the Clinical Evidence Base for MRace as a Treatment Option for FMR Patients With Complex M-TEER Anatomies (FR)Polares Medical SANot Yet RecruitingNot Applicable
NCT07757607Not Yet Recruiting
Not Applicable
A Prospective, Multicenter, Single-Arm Study to Support the Clinical Evidence Ba...Polares Medical SA
NCT07758972
Safety and Immunogenicity Study of a Multivalent Gonorrhoea VaccineGerman Federal Ministry of Education and ResearchRecruitingPhase 1
NCT07758972Recruiting
Phase 1
Safety and Immunogenicity Study of a Multivalent Gonorrhoea VaccineGerman Federal Ministry o...
NCT07757672
Salvage Chemotherapy With Sonrotoclax, Cladribine, and Standard-dose Cytarabine, Sequentially Followed by HSCT for R/R AML.Institute of Hematology & Blood Diseases Hospital, ChinaNot Yet RecruitingPhase 1
NCT07757672Not Yet Recruiting
Phase 1
Salvage Chemotherapy With Sonrotoclax, Cladribine, and Standard-dose Cytarabine,...Institute of Hematology &...
NCT07758894
Non-Intubated Anesthesia for Adult Heart TransplantationThe First Affiliated Hospital of Guangzhou Medical UniversityRecruitingNot Applicable
NCT07758894Recruiting
Not Applicable
Non-Intubated Anesthesia for Adult Heart TransplantationThe First Affiliated Hosp...
NCT07757165
The Necessity of Surgery in Patients With mGC Achieving Radiological Response After Conversion TherapyFudan UniversityRecruitingPhase 2
NCT07757165Recruiting
Phase 2
The Necessity of Surgery in Patients With mGC Achieving Radiological Response Af...Fudan University
NCT07758218
Allogeneic iNKT Cell Therapy (agenT-797) After SCTUniversity of Wisconsin, MadisonNot Yet RecruitingPhase 1
NCT07758218Not Yet Recruiting
Phase 1
Allogeneic iNKT Cell Therapy (agenT-797) After SCTUniversity of Wisconsin,...
NCT07756736
Psilocybin Therapy for Methamphetamine Use Disorder and HIVNational Institute on Drug Abuse (NIDA)Not Yet RecruitingPhase 2
NCT07756736Not Yet Recruiting
Phase 2
Psilocybin Therapy for Methamphetamine Use Disorder and HIVNational Institute on Dru...
NCT07757685
Autologous Hematopoietic Stem Cell Transplantation for Neurological Damage Associated With Hereditary Homocysteine Remethylation DisordersInstitute of Hematology & Blood Diseases Hospital, ChinaNot Yet RecruitingNot Applicable
NCT07757685Not Yet Recruiting
Not Applicable
Autologous Hematopoietic Stem Cell Transplantation for Neurological Damage Assoc...Institute of Hematology &...
NCT07758621
SYS6010 vs Investigator's Choice of Monotherapy in Patients With Recurrent or Metastatic HNSCCCSPC Megalith Biopharmaceutical Co.,Ltd.Not Yet RecruitingPhase 3
NCT07758621Not Yet Recruiting
Phase 3
SYS6010 vs Investigator's Choice of Monotherapy in Patients With Recurrent or Me...CSPC Megalith Biopharmace...
Result Breakdown
Not yet recruiting11 (55%)
Recruiting6 (30%)
Completed2 (10%)
Active, not recruiting1 (5%)
not_applicable7 (35%)
Not Specified5 (25%)
Phase 24 (20%)
Phase 13 (15%)
Phase 31 (5%)